Company Overview of Taiga Biotechnologies, Inc.
Taiga Biotechnologies, Inc. develops therapeutic approaches to treat hematological diseases, including cancers, immunodeficiencies, and autoimmune conditions. It develops stem-cell therapeutics and red blood cells, biologics, and small molecules. The company was founded in 2006 and is based in Aurora, Colorado.
12635 East Montview Boulevard
Fitzsimons Bioscience Park
Aurora, CO 80045-7336
Founded in 2006
Key Executives for Taiga Biotechnologies, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
March 16, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Taiga Biotechnologies, Inc., please visit www.taigabiotech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.